Clinical Trials on Immune Checkpoints Inhibitors in Australia

Total 2408 results

Bayside Health
The Alfred

Unknown

Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease

Asthma | Cystic Fibrosis | Bronchiolitis Obliterans | Lung Transplantation

Australia
Medical University of Vienna

Completed

MTF Image Modifications

Visual Acuity | Contrast Sensitivity | Modulation Transfer Function

Austria
Community and Patient Preference Research Pty Ltd
Seqirus; Glenmark Pharmaceuticals S.A.

Completed

Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray

Allergic Rhinitis

Australia
AstraZeneca
Takeda

Completed

Diabetic Retinopathy Candesartan Trials (DIRECT)

Type 1 Diabetes

Denmark, Australia
invIOs GmbH

Recruiting

PBMC-based Leukocyte Immunotherapy (PALINDROM)

Advanced Solid Tumor

Austria
GlaxoSmithKline

Completed

A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers

Asthma

Australia
University of Sydney
AbbVie

No longer available

99m-Technetium- Glucosamine in Arthritis

Rheumatoid Arthritis | Ankylosing Spondylitis

Australia
Medical University of Graz

Completed

The Effect of Antihypertensive Drugs on Severity of Anaphylaxis and Side-effects During Venom Immunotherapy (EADOAS)

Hymenoptera Venom Allergy | Antihypertensive Treatment

Austria
Medical University of Vienna

Unknown

Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy

Food Allergy | Anaphylaxis

Austria
St Vincent's Hospital, Sydney
Merck Sharp & Dohme LLC; The Alfred; Holdsworth House Medical Practice

Completed

Switch From Tenofovir to Raltegravir for Low Bone Mineral Density (TROP)

HIV Infections | HIV | Osteoporosis | Osteopenia

Australia
Charite University, Berlin, Germany

Terminated

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Post-transplantation Lymphoproliferative Disorder

Australia, France, Germany, Sweden
The University of New South Wales
National Health and Medical Research Council, Australia; Novo Nordisk A/S; Sydney...

Completed

Rosiglitazone and Insulin in T1DM Adolescents

Type 1 Diabetes | Puberty: >Tanner 2 Breast Development or Testis >4ml

Australia
Austin Health
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study (AvR-CHOP)

Lymphomas Non-Hodgkin's B-Cell

Australia
Medical University of Graz

Recruiting

Is the BAT Inhibition Able to Replace Sting Challenges? (BATIRS)

Vespid Venom Allergy

Austria
Holdsworth House Medical Practice
Atomo Diagnostics

Completed

Performance and Usability Evaluation of the Atomo HIV Self-Test

HIV Infections

Australia
Biogen

Completed

Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta (RENeu)

Relapsing-Remitting Multiple Sclerosis

New Zealand, Australia
Kirby Institute
Hoffmann-La Roche

Completed

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study (ASK-500)

HIV Infections

Australia
Faes Farma, S.A.

Completed

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Chronic Urticaria | Allergic Rhinoconjunctivitis

Australia, Germany, Sweden
Andrew Carr
Merck Sharp & Dohme LLC

Completed

Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men (RAL-NPEP)

HIV Infections | HIV Prevention

Australia
Medical University of Graz

Recruiting

Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure (PREDICT)

Bee Venom Allergy

Austria
Bayside Health

Completed

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Non-Hodgkin's Lymphoma | Hodgkin's Disease

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
Kirby Institute

Completed

Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. (ENCORE1)

HIV Infections

Australia
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

HIV Infections

Australia
Novo Nordisk A/S

Recruiting

A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

Haemophilia A With Inhibitors | Haemophilia A

United States, Korea, Republic of, France, Spain, Romania, Canada, Taiwan, China, Lithuania, Netherlands, India, South Africa, Russian Federation, Austria, Belgium, Czechia, Denmark, Germany, Ireland, Italy, Japan, Latvia, Malaysia, M... and more
Community and Patient Preference Research Pty Ltd
Seqirus Limited; Glenmark Pharmaceuticals

Withdrawn

Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes

Allergic Rhinitis

Australia
Novo Nordisk A/S

Recruiting

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4) (FRONTIER4)

Haemophilia A With Inhibitors | Haemophilia A

Taiwan, Canada, Spain, Netherlands, Korea, Republic of, India, United States, United Kingdom, Portugal, Lithuania, Turkey, China, South Africa, Ireland, Italy, France, Japan, Belgium, Germany, Malaysia, Poland, Austria, Bulgaria, Denmark and more
Aravax Pty Ltd

Recruiting

A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

Immune System Diseases | Peanut Hypersensitivity | Peanut Allergy | Peanut-Induced Anaphylaxis

United States, Australia
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease

Asthma

Korea, Republic of, New Zealand, Australia, Poland, Thailand, Spain
Medical University of Graz

Completed

Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans

Healthy Humans

Austria
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Multiple Myeloma | Cutaneous Lymphoma

Australia
Kirby Institute
University of Public Health, Myanmar

Completed

Simplified Monitoring Myanmar SM2 Study (SM2)

HIV Infections | Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Biomay AG

Completed

Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

Hypersensitivity

Austria
Medical University of Graz

Completed

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial (ENM-HS-001)

Diabetes, Type I

Austria
The University of Queensland

Not yet recruiting

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside (ATNAD)

Ataxia Telangiectasia

Australia
Principia Biopharma, a Sanofi Company

Active, not recruiting

A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia | Immune Thrombocytopenic Purpura

United States, Australia, Bulgaria, Canada, Czechia, Netherlands, Norway, United Kingdom
Hoffmann-La Roche

Completed

An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

Australia
Novartis Pharmaceuticals

Recruiting

Characterizing the Use of Ofatumumab in a Real World Setting (EAFToS)

Relapsing Multiple Sclerosis

Australia
Murdoch Childrens Research Institute
National Health and Medical Research Council, Australia; Royal Children's Hospital and other collaborators

Recruiting

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents (GenV)

Communicable Diseases | Quality of Life | Inflammation | Obesity | Congenital Abnormalities | Genetics | Healthy Aging | Child Development | Diet | Mental Health | Disability | Injuries | Cognition | Child Health | Environmental Exposure | Noncommunicable Diseases | Physical Fitness | Intergenerational Relations | Social Determinants... and other conditions

Australia
The University of Queensland
National Health and Medical Research Council, Australia

Completed

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis (A-TC7)

Ataxia Telangiectasia

Australia
Peter MacCallum Cancer Centre, Australia
Hoffmann-La Roche

Active, not recruiting

A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) (COALITION)

Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma

Australia
Biomay AG
Medical University of Vienna

Completed

Skin Test Study of BM32

Hypersensitivity

Austria
GlaxoSmithKline

Completed

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Rhinitis, Allergic, Perennial and Seasonal

Australia
Kirby Institute

Completed

Raltegravir and Atazanavir Dosing Strategy Study (SPARTA)

HIV Infection

Australia
Iksuda Therapeutics Ltd.

Recruiting

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

Follicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin Lymphoma

Australia, Canada, United States
Mundipharma Research Limited

Terminated

A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab. (ROBIN)

Indolent B-cell NHL

Australia, Slovakia
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Gilead Sciences; Hoffmann-La... and other collaborators

Terminated

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

HIV Infections | HIV-Associated Lipodystrophy

Australia
EpimAb Biotherapeutics (Suzhou)Co., Ltd.

Recruiting

First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma

Advanced/Metastatic Solid Tumors | Relapse/Refractory Lymphoma

China, Australia
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia

Acute Leukemias

Hungary, Belgium, Germany, Austria, Netherlands, Australia, Canada, Spain, Norway, United Kingdom, United States
Kirby Institute
National Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaborators

Completed

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Glucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | Lipodystrophy

Australia

Clinical Trials on Immune Checkpoints Inhibitors in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations